Pharmaceutical Executive Bioethics Roundtable

Bioethics International & Yale School of Medicine’s Pharmaceutical Executive Roundtable

Hosted by Deloitte

This year’s bioethics roundtable, our 13th!, will focus on equity and social responsibility in the bio-pharmaceutical sector and debut the new Good Pharma Scorecard (GPS) company rankings on diversity and fair inclusion in research. We will also eplore emerging ESG measures for the life sciences sector.

Featured Speakers

Neil Lesser, Principal, Life Sciences R&D and Sustainability/Equity Practice Leader, Deloitte Jennifer E. Miller, Associate Professor, Yale School of Medicine; Founder, Bioethics International Kimberly Sabelko, VP, Scientific Strategy & Programs, Susan G. Komen Foundation David Leventhal, Enterprise Clinical Trial Data Sharing Lead, Pfizer, Inc. Martin Mendoza, Director Health Equity, All of Us Research Program, NIH

Patrice Matchaba, Head, US Corporate Responsibility; President, Novartis Foundation Pierre Theodore, VP, Global Public Health, Johnson & Johnson Jessica Scott, President, Legacy Health Strategies Marc Wilenzick, Associate General Counsel, Gilead Catharine Grimes, President, Bristol Myers Squibb Foundation Lauren Puffer, Director, Sustainability Banking, Cowen

When: June 9, 2022 – 9am-4:15pm ET

Location: Deloitte’s NYC Offices

Register Here: Pharma Executive Roundtable RSVP Form

BI Roundtable Flyer